The new research report prepared by Market.us Research is titled ” Interleukin 7 Receptor Subunit Alpha Analysis with Future Scope, Current Market Scenario, and Forecast to 2029. ” The business ...
Antitumour necrosis factor alpha (anti-TNFα) agents include infliximab, adalimumab, golimumab, AVX-470 and OPRX-106. Janus kinase (JAK) inhibitors: tofacitinib, filgotinib and upadacitinib. Cytokine ...
SAN JOSE, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback